Exercising during the day is associated with an increased risk of developing nocturnal hypoglycemia among patients with type 1 diabetes.
Researchers evaluated the efficacy of cagrilintide-semaglutide vs semaglutide alone in adults with inadequately controlled type 2 diabetes.